Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)

Launched by BEIJING DITAN HOSPITAL · Oct 10, 2021

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meet the criteria of hepatocellular carcinoma
• • Patients who tested positive for hepatitis B surface antigen (HBsAg) for \>6 months
• • Meet the criteria of anemia
• • Ages Eligible for Study: ≤75 years old;
• • Informed consent from the patient.
• Exclusion Criteria:
• • Patients with upper gastrointestinal bleeding within 3 months before enrollment;
• • History of blood transfusion within 3 months before enrollment;
• • Patient with other chronic hepatopathy, such as AIH, NAFLD, ALD;
• • Serious problem of heart, lung, or kidney with severe dysfunction;
• • Pregnant or child breast feeding women;
• • Mental or cognitive disorders;
• • Participating in other drug trials;
• • Who are allergic to the study drug.